Sickle cell disease is caused by an alteration in a single DNA base, but its clinical manifestations are influenced by other genes and behavioral and environmental factors …
Background The global burden of sickle cell anaemia (SCA) is set to rise as a consequence of improved survival in high-prevalence low-and middle-income countries and population …
Background Hydroxyurea is an effective treatment for sickle cell anemia, but few studies have been conducted in sub-Saharan Africa, where the burden is greatest. Coexisting …
D Lubeck, I Agodoa, N Bhakta, M Danese… - JAMA network …, 2019 - jamanetwork.com
Importance Individuals with sickle cell disease (SCD) have reduced life expectancy; however, there are limited data available on lifetime income in patients with SCD. Objective …
Executive summary All over the world, people with sickle cell disease (an inherited condition) have premature deaths and preventable severe chronic complications, which …
KL Hassell - American journal of preventive medicine, 2010 - Elsevier
BACKGROUND: The number of individuals with sickle cell disease (SCD) in the US is unknown. Determination of burden of disease, healthcare issues, and policies is best served …
CT Quinn, ZR Rogers, TL McCavit… - Blood, The Journal of …, 2010 - ashpublications.org
The survival of young children with sickle cell disease (SCD) has improved, but less is known about older children and adolescents. We studied the Dallas Newborn Cohort (DNC) …
B Ranque, R Kitenge, DD Ndiaye, MD Ba… - The Lancet …, 2022 - thelancet.com
Background Many children with sickle cell disease living in sub-Saharan Africa die before reaching age 5 years. We estimate the child mortality associated with sickle cell anaemia …
BPD Inusa, LL Hsu, N Kohli, A Patel… - International journal of …, 2019 - mdpi.com
Sickle cell disease (SCD) is a monogenetic disorder due to a single base-pair point mutation in the β-globin gene resulting in the substitution of the amino acid valine for glutamic acid in …